Robert P. Woroniecki

Dr. Robert P. Woroniecki

Division of Pediatric Nephrology and Hypertension, Stony Brook Children's Hospital, Stony Brook, New York, NY, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in The Lancet Child & Adolescent Health
Verified
Journal Article
Closed access
JJJennifer G. Jetton
Jennifer G. Jetton
LBLouis J. Boohaker
Louis J. Boohaker
SSSidharth Kumar Sethi
Sidharth Kumar Sethi
SWSanjay Wazir
Sanjay Wazir
SRSmriti Rohatgi
Smriti Rohatgi
DADavid J. Askenazi
David J. Askenazi


1 February 2009 in The Journal of Pediatrics
Verified
Journal Article
Closed access
JKJuhi Kumar
Juhi Kumar
RGRoberto Gordillo
Roberto Gordillo
FKFrederick J. Kaskel
Frederick J. Kaskel
CDCharlotte M. Druschel
Charlotte M. Druschel
Robert P. WoronieckiRobert P. Woroniecki
Robert P. Woroniecki

1 May 2008 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
JLJohan Lorenzen
Johan Lorenzen
RSRajshree Shah
Rajshree Shah
ABAlisha Biser
Alisha Biser
SSSerban A. Staicu
Serban A. Staicu
TNThiruvur Niranjan
Thiruvur Niranjan
KSKatalin Susztak
Katalin Susztak
Several gene array studies have suggested that osteopontin (Opn) expression strongly correlates with albuminuria and glomerular disease. Urinary Opn concentration and kidney Opn immunoreactivity were found to be increased in patients with steroid-sensitive nephrotic syndrome. In addition, renal Opn mRNA was increased in the Ins2Akita mouse model of type 1 diabetic nephropathy, in the LPS-induced albuminuria model, and in glomeruli of puromycin aminonucleotide–induced nephrotic rats. Opn knockout mice did not develop albuminuria in response to LPS injection, and Opn knockout mice were protected from diabetes-induced albuminuria and mesangial expansion. In the glomerulus, Opn immunostaining was increased specifically in podocytes. Treatment of podocytes with recombinant Opn activated the NF-κB pathway, increased expression of urokinase plasminogen activator and matrix metalloproteinases 2 and 9, and increased podocyte motility. Taken together, these results indicate that Opn plays an important role in the development of albuminuria, possibly by modulating podocyte signaling and motility.

27 April 2016 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
DNDerek K. Ng
Derek K. Ng
CRCatherine C. Robertson
Catherine C. Robertson
Robert P. WoronieckiRobert P. Woroniecki
Robert P. Woroniecki
SLSophie Limou
Sophie Limou
CGChristopher E. Gillies
Christopher E. Gillies
MSMatthew G. Sampson
Matthew G. Sampson
Background: Individuals of African ancestry harboring two variant alleles within apolipoprotein L1 (APOL1) are classified with a high-risk (HR) genotype. Adults with an HR genotype have increased risk of focal segmental glomerulosclerosis and chronic kidney disease compared with those with a low-risk (LR) genotype (0 or 1 variants). The role of APOL1 risk genotypes in children with glomerular disease is less well known. Methods: This study characterized 104 African-American children with a glomerular disease by APOL1 genotype in two cohorts: the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE). Results: Among these subjects, 46% had an HR genotype with a similar age at cohort enrollment. For APOL1 HR children, the median age of disease onset was older (CKiD: 4.5 versus 11.5 years for LR versus HR; NEPTUNE: 11 versus 14 years for LR versus HR, respectively) and preterm birth was more common [CKiD: 27 versus 4%; NEPTUNE: 26 versus 12%; combined odds ratio 4.6 (95% confidence interval: 1.4, 15.5)]. Within studies, HR children had lower initial estimated glomerular filtration rate (eGFR) (CKiD: 53 versus 69 mL/min/1.73 m2; NEPTUNE: 74 versus 94 mL/min/1.73 m2). Longitudinal eGFR decline was faster among HR children versus LR (CKiD: −18 versus −8% per year; NEPTUNE: −13 versus −3% per year). Conclusions: Children with an HR genotype in CKiD and NEPTUNE seem to have a more aggressive form of glomerular disease, in part due to a higher prevalence of focal segmental glomerulosclerosis. These consistent findings across independent cohorts suggest a common natural history for children with APOL1-associated glomerular disease. Further study is needed to determine the generalizability of these findings.

10 June 2016 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
SMSandeep Mallipattu
Sandeep Mallipattu
YGYiqing Guo
Yiqing Guo
MRMonica P. Revelo
Monica P. Revelo
LRLucia Roa-Peña
Lucia Roa-Peña
TMTimothy Miller
Timothy Miller
JHJohn C. He
John C. He
Podocyte injury is the inciting event in primary glomerulopathies, such as minimal change disease and primary FSGS, and glucocorticoids remain the initial and often, the primary treatment of choice for these glomerulopathies. Because inflammation is not readily apparent in these diseases, understanding the direct effects of glucocorticoids on the podocyte, independent of the immunomodulatory effects, may lead to the identification of targets downstream of glucocorticoids that minimize toxicity without compromising efficacy. Several studies showed that treatment with glucocorticoids restores podocyte differentiation markers and normal ultrastructure and improves cell survival in murine podocytes. We previously determined that Krüppel–like factor 15 (KLF15), a kidney–enriched zinc finger transcription factor, is required for restoring podocyte differentiation markers in mice and human podocytes under cell stress. Here, we show that in vitro treatment with dexamethasone induced a rapid increase of KLF15 expression in human and murine podocytes and enhanced the affinity of glucocorticoid receptor binding to the promoter region of KLF15. In three independent proteinuric murine models, podocyte-specific loss of Klf15 abrogated dexamethasone–induced podocyte recovery. Furthermore, knockdown of KLF15 reduced cell survival and destabilized the actin cytoskeleton in differentiated human podocytes. Conversely, overexpression of KLF15 stabilized the actin cytoskeleton under cell stress in human podocytes. Finally, the level of KLF15 expression in the podocytes and glomeruli from human biopsy specimens correlated with glucocorticoid responsiveness in 35 patients with minimal change disease or primary FSGS. Thus, these studies identify the critical role of KLF15 in mediating the salutary effects of glucocorticoids in the podocyte.